LIERMAN TERRY L 4
4 · IGC Pharma, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
LIERMAN TERRY L
Director
Transactions
- Award
OPTIONS
2024-03-13+150,000→ 150,000 totalExercise: $0.30Exp: 2034-03-12→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents 150,000 options to buy shares of common stock, 50,000 vesting immediately and 100,000 subject to vesting over two years in equal parts starting 2025, as per the IGC Board of Directors Agreement with Mr. Lierman.
- [F2]Exercisable in equal amounts on March 2024, 2025 & 2026.